These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 15717013)

  • 1. The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.
    Leegwater-Kim J; Cha JH
    NeuroRx; 2004 Jan; 1(1):128-38. PubMed ID: 15717013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on Huntington's disease.
    Berman SB; Greenamyre JT
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):281-6. PubMed ID: 16822347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Huntington chorea. Animal models reveal new hypotheses for pathophysiology and therapy].
    Kosinski CM; Cha JH; Young AB; Schwarz M
    Nervenarzt; 1999 Oct; 70(10):878-88. PubMed ID: 10554779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of novel therapies for Huntington's disease: hope and challenge.
    Qin ZH; Wang J; Gu ZL
    Acta Pharmacol Sin; 2005 Feb; 26(2):129-42. PubMed ID: 15663888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntington's disease: pathogenesis to animal models.
    Kumar P; Kalonia H; Kumar A
    Pharmacol Rep; 2010; 62(1):1-14. PubMed ID: 20360611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective neuronal degeneration in Huntington's disease.
    Cowan CM; Raymond LA
    Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huntington's disease: pathological mechanisms and therapeutic strategies.
    Ramaswamy S; Shannon KM; Kordower JH
    Cell Transplant; 2007; 16(3):301-12. PubMed ID: 17503740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington's disease: prospects for neuroprotective therapy 10 years after the discovery of the causative genetic mutation.
    Hersch SM
    Curr Opin Neurol; 2003 Aug; 16(4):501-6. PubMed ID: 12869810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic mechanisms of neurodegeneration in Huntington's disease.
    Lee J; Hwang YJ; Kim KY; Kowall NW; Ryu H
    Neurotherapeutics; 2013 Oct; 10(4):664-76. PubMed ID: 24006238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments.
    Roze E; Saudou F; Caboche J
    Curr Opin Neurol; 2008 Aug; 21(4):497-503. PubMed ID: 18607213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease.
    Milnerwood AJ; Raymond LA
    Trends Neurosci; 2010 Nov; 33(11):513-23. PubMed ID: 20850189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial-associated metabolic changes and neurodegeneration in Huntington's disease - from clinical features to the bench.
    Rosenstock TR; Duarte AI; Rego AC
    Curr Drug Targets; 2010 Oct; 11(10):1218-36. PubMed ID: 20840066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNAs in Huntington's disease neurodegeneration.
    Johnson R
    Neurobiol Dis; 2012 May; 46(2):245-54. PubMed ID: 22202438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current perspectives in the treatment of Huntington's chorea].
    Kuran W
    Neurol Neurochir Pol; 2002; 36(4):757-65. PubMed ID: 12418139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection for Huntington's disease: ready, set, slow.
    Hersch SM; Rosas HD
    Neurotherapeutics; 2008 Apr; 5(2):226-36. PubMed ID: 18394565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's disease: an update of therapeutic strategies.
    Kumar A; Kumar Singh S; Kumar V; Kumar D; Agarwal S; Rana MK
    Gene; 2015 Feb; 556(2):91-7. PubMed ID: 25447911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanisms of neuronal death in Huntington's disease. Second part: therapeutic challenges].
    Bantubungi K; Blum D
    Rev Med Brux; 2007; 28(6):487-94. PubMed ID: 18265808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington's disease.
    Wang SE; Lin CL; Hsu CH; Sheu SJ; Chien CT; Wu CH
    Drug Des Devel Ther; 2015; 9():887-900. PubMed ID: 25733809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of mitochondria in the pathogenesis of Huntington's disease].
    Karachitos A; Gałgańska H; Kmita H
    Postepy Biochem; 2010; 56(2):174-81. PubMed ID: 20873112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease.
    Gil JM; Rego AC
    Brain Res Rev; 2009 Mar; 59(2):410-31. PubMed ID: 19118572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.